BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19855174)

  • 1. Cancer vaccines and immunotherapy.
    Tang H
    Hum Vaccin; 2009 Oct; 5(10):666. PubMed ID: 19855174
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer vaccines: what do we need to measure in clinical trials?
    Kudrin A
    Hum Vaccin Immunother; 2014; 10(11):3236-40. PubMed ID: 25483508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for cancer: focusing on developing treatments rather than drugs.
    Sznol M
    Curr Opin Investig Drugs; 2001 Jul; 2(7):957-8. PubMed ID: 11757798
    [No Abstract]   [Full Text] [Related]  

  • 4. Increasing immunogenicity of cancer vaccines to improve their clinical outcome.
    Parmiani G; Cimminiello C; Maccalli C
    Expert Rev Vaccines; 2013 Oct; 12(10):1111-3. PubMed ID: 24124873
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer vaccines 2000.
    Tartour E; Fridman WH
    Immunol Lett; 2000 Sep; 74(1):1-3. PubMed ID: 10996621
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer vaccines: toward the next revolution in cancer therapy.
    Emens LA
    Int Rev Immunol; 2006; 25(5-6):259-68. PubMed ID: 17169776
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer.
    Berzofsky JA; Wood LV; Terabe M
    Expert Rev Vaccines; 2013 Oct; 12(10):1115-8. PubMed ID: 24124874
    [No Abstract]   [Full Text] [Related]  

  • 8. [New directions in immunotherapy for malignant solid tumors].
    Okuno K; Sugiura F; Sukegawa Y; Inoue K
    Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
    Nelson B
    Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
    [No Abstract]   [Full Text] [Related]  

  • 10. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
    Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
    Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
    [No Abstract]   [Full Text] [Related]  

  • 11. MUC1 as a target antigen for cancer immunotherapy.
    Acres B; Limacher JM
    Expert Rev Vaccines; 2005 Aug; 4(4):493-502. PubMed ID: 16117706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention is better than cure: the case for clinical trials of therapeutic cancer vaccines in the prophylactic setting.
    Gray A; Yan L; Kast WM
    Mol Interv; 2010 Aug; 10(4):197-203. PubMed ID: 20729485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in therapeutic cancer vaccines.
    Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
    Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fourth pillar: Despite some setbacks in the clinic, immunotherapy has made notable progress toward becoming an additional therapeutic option against cancer.
    Hunter P
    EMBO Rep; 2017 Nov; 18(11):1889-1892. PubMed ID: 29021204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rekindling cancer vaccines.
    Branca MA
    Nat Biotechnol; 2016 Oct; 34(10):1019-1024. PubMed ID: 27727216
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic cancer vaccines: From initial findings to prospects.
    Song Q; Zhang CD; Wu XH
    Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.
    Khatami F; Torabi-Rahvar M; Kiani J; Naderi M; Ahmadbeigi N
    Cytotherapy; 2018 Oct; 20(10):1227-1237. PubMed ID: 30266521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
    Fournier P; Schirrmacher V
    Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.